Treatment of Carcinoma of the Fallopian Tube Using Cisplatin, Doxorubicin, and Cyclophosphamide
- 1 October 1986
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 9 (5) , 436-439
- https://doi.org/10.1097/00000421-198610000-00015
Abstract
Nine patients with metastatic carcinoma of the fallopian tube were treated with a combination of cisplatin, doxorubicin, and cyclophosphamide. Three are in complete clinical reat 18–56 months following the onset of chemotherapy. Two others died of intercurrent causes without evidence of disease. The remaining four died of tumor at 12, 23, 28, and 52 months following the initiation of treatment. Four second-look laparotomieS were performed upon patients who were in complete clinical remission. No disease was found in any of these patients. It is concluded that this combination is an effective treatment foradenocareinoma of the fallopian tube, and that second-look laparotomy may be useful in assessing respdnse to chemotherapy in this disease.This publication has 4 references indexed in Scilit:
- FALLOPIAN-TUBE CARCINOMA1984
- Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1983
- PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE1981
- COMBINATION CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE FALLOPIAN-TUBE1980